메뉴 건너뛰기




Volumn 34, Issue 3, 2011, Pages 264-269

Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors

Author keywords

glioma; imiquimod; immunotherapy; Toll like receptor; vaccine

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMIQUIMOD; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR FOXP3;

EID: 79953065996     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e318209eed4     Document Type: Article
Times cited : (37)

References (16)
  • 1
    • 67649884707 scopus 로고    scopus 로고
    • Beyond a decade of 5% imiquimod topical therapy
    • A Gaspari A, Tyring SK, Rosen T. Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol. 2009;8:467-474.
    • (2009) J Drugs Dermatol , vol.8 , pp. 467-474
    • Gaspari A, A.1    Tyring, S.K.2    Rosen, T.3
  • 2
    • 0141886220 scopus 로고    scopus 로고
    • IFN-α skews monocyte differentiation into toll-like receptor 7-expressing dendritic cells with potent functional activities
    • Mohty M, Vialle-Castellano A, Nunes JA, et al. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J Immunol. 2003;171:3385-3393. (Pubitemid 37254538)
    • (2003) Journal of Immunology , vol.171 , Issue.7 , pp. 3385-3393
    • Mohty, M.1    Vialle-Castellano, A.2    Nunes, J.A.3    Isnardon, D.4    Olive, D.5    Gaugler, B.6
  • 3
    • 50649093779 scopus 로고    scopus 로고
    • The use of TLR7 and TLR8 ligands for the enhancement of cancer immunother-apy
    • Smits EL, Ponsaerts P, Berneman ZN, et al. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunother-apy. Oncologist. 2008;13:859-875.
    • (2008) Oncologist , vol.13 , pp. 859-875
    • Smits, E.L.1    Ponsaerts, P.2    Berneman, Z.N.3
  • 4
    • 33644665904 scopus 로고    scopus 로고
    • Imiquimod as an antiangiogenic agent
    • Li VW, Li WW, Talcott KE, et al. Imiquimod as an antiangiogenic agent. J Drugs Dermatol. 2005;4:708-717.
    • (2005) J Drugs Dermatol , vol.4 , pp. 708-717
    • Li, V.W.1    Li, W.W.2    Talcott, K.E.3
  • 5
    • 0347320541 scopus 로고    scopus 로고
    • Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures
    • Meyer T, Nindl I, Schmook T, et al. Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br J Dermatol. 2003;149(suppl 66):9-14.
    • (2003) Br J Dermatol , vol.149 , Issue.SUPPL. 66 , pp. 9-14
    • Meyer, T.1    Nindl, I.2    Schmook, T.3
  • 6
    • 75149134844 scopus 로고    scopus 로고
    • More than a decade on: Review of the use of imiquimod in lower anogenital intra-epithelial neoplasia
    • Mahto M, Nathan M, O'Mahony C. More than a decade on: review of the use of imiquimod in lower anogenital intra-epithelial neoplasia. Int J STD AIDS. 2010;21:8-16.
    • (2010) Int J STD AIDS , vol.21 , pp. 8-16
    • Mahto, M.1    Nathan, M.2    O'Mahony, C.3
  • 7
    • 66949170320 scopus 로고    scopus 로고
    • Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy
    • Broomfield SA, van der Most RG, Prosser AC, et al. Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy. J Immunol. 2009;182:5217-5224.
    • (2009) J Immunol , vol.182 , pp. 5217-5224
    • Broomfield, S.A.1    Van Der Most, R.G.2    Prosser, A.C.3
  • 8
    • 29644446061 scopus 로고    scopus 로고
    • The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: Relation to central nervous system antitumor immunity
    • Prins RM, Craft N, Bruhn KW, et al. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. J Immunol. 2006;176: 157-164. (Pubitemid 43023259)
    • (2006) Journal of Immunology , vol.176 , Issue.1 , pp. 157-164
    • Prins, R.M.1    Craft, N.2    Bruhn, K.W.3    Khan-Farooqi, H.4    Koya, R.C.5    Stripecke, R.6    Miller, J.F.7    Liau, L.M.8
  • 9
    • 34249056542 scopus 로고    scopus 로고
    • Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma
    • DOI 10.1038/sj.cgt.7701045, PII 7701045
    • Wu A, Oh S, Ericson K, et al. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther. 2007;14:550-560. (Pubitemid 46788330)
    • (2007) Cancer Gene Therapy , vol.14 , Issue.6 , pp. 550-560
    • Wu, A.1    Oh, S.2    Ericson, K.3    Demorest, Z.L.4    Vengco, I.5    Gharagozlou, S.6    Chen, W.7    Low, W.C.8    Ohlfest, J.R.9
  • 11
    • 53049095387 scopus 로고    scopus 로고
    • Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis
    • Xiong Z, Gharagozlou S, Vengco I, et al. Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis. Clin Cancer Res. 2008;14:5484-5493.
    • (2008) Clin Cancer Res , vol.14 , pp. 5484-5493
    • Xiong, Z.1    Gharagozlou, S.2    Vengco, I.3
  • 12
    • 34347232370 scopus 로고    scopus 로고
    • Intracellular cytokine optimization and standard operating procedure
    • Lamoreaux L, Roederer M, Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc. 2006;1:1507-1516.
    • (2006) Nat Protoc , vol.1 , pp. 1507-1516
    • Lamoreaux, L.1    Roederer, M.2    Koup, R.3
  • 14
    • 37349114848 scopus 로고    scopus 로고
    • In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma
    • DOI 10.1097/CJI.0b013e318155a0f6, PII 0000237120071100000001
    • Wu A, Oh S, Gharagozlou S, et al. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. J Immunother. 2007;30:789-797. (Pubitemid 350295357)
    • (2007) Journal of Immunotherapy , vol.30 , Issue.8 , pp. 789-797
    • Wu, A.1    Oh, S.2    Gharagozlou, S.3    Vedi, R.N.4    Ericson, K.5    Low, W.C.6    Chen, W.7    Ohlfest, J.R.8
  • 15
    • 33947574347 scopus 로고    scopus 로고
    • The antitumoral mode of action of imiquimod and other imidazoquinolines
    • DOI 10.2174/092986707780059625
    • Schon M, Schon MP. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem. 2007;14:681-687. (Pubitemid 46477720)
    • (2007) Current Medicinal Chemistry , vol.14 , Issue.6 , pp. 681-687
    • Schon, M.1    Schon, M.P.2
  • 16
    • 33644770260 scopus 로고    scopus 로고
    • Adenosine receptors as therapeutic targets
    • DOI 10.1038/nrd1983, PII N1983
    • Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006;5:247-264. (Pubitemid 43336037)
    • (2006) Nature Reviews Drug Discovery , vol.5 , Issue.3 , pp. 247-264
    • Jacobson, K.A.1    Gao, Z.-G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.